All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @carlyscarlato on TikTok · 9s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @carlyscarlato's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00You

Peptides and babies: what TikTok auntie content gets wrong

Carly Scarlato

TikTok creator

29.6K viewsWatch on TikTok

Quick answer

Peptide therapies occupy a complex regulatory and evidence space: some compounds have promising preclinical data, but human RCT evidence remains sparse for most wellness applications. The FDA's 2023 removal of BPC-157 and TB-500 from compounding bulk substance lists reflects ongoing safety and efficacy concerns. Any peptide regimen should be evaluated by a licensed provider with appropriate diagnostic context.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptides and babies: what TikTok auntie content gets wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptides and babies: what TikTok auntie content gets wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptides and babies: what TikTok auntie content gets wrong" from Carly Scarlato. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Peptide therapies occupy a complex regulatory and evidence space: some compounds have promising preclinical data, but human RCT evidence remains sparse for most wellness applications.

The reason this review is not generic is the source wording and the canonical claim label "peptides can t wait to spoil you auntie aunt firsttimeauntie firsttim." In this clip, the useful excerpt is: "You" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

BPC-157 and TB-500 were removed from the FDA's compounding bulk substances list in 2023, creating legal and safety uncertainty for compounded versions.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Peptide therapies occupy a complex regulatory and evidence space: some compounds have promising preclinical data, but human RCT evidence remains sparse for most wellness applications.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Peptide therapies occupy a complex regulatory and evidence space: some compounds have promising preclinical data, but human RCT evidence remains sparse for most wellness applications. The FDA's 2023 removal of BPC-157 and TB-500 from compounding bulk substance lists reflects ongoing safety and efficacy concerns. Any peptide regimen should be evaluated by a licensed provider with appropriate diagnostic context.
  • No peptide in this category holds FDA approval for general wellness or anti-aging use as of 2024.
  • BPC-157 and TB-500 were removed from the FDA's compounding bulk substances list in 2023, creating legal and safety uncertainty for compounded versions.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • No peptide in this category holds FDA approval for general wellness or anti-aging use as of 2024.
  • BPC-157 and TB-500 were removed from the FDA's compounding bulk substances list in 2023, creating legal and safety uncertainty for compounded versions.
  • Human RCT evidence for most wellness peptide claims is either absent or based on small, tightly controlled clinical populations that don't represent general use.
  • Growth hormone-stimulating peptides carry documented adverse effects including insulin resistance, fluid retention, and joint pain even in supervised study settings.
  • Compounded peptide preparations can vary significantly in potency and purity, a risk that lifestyle content rarely addresses.
  • MK-677, often grouped with peptides, is a synthetic secretagogue not approved for human use outside of clinical trials in the U.S.
  • Emotional or lifestyle framing in health content does not change the underlying evidence base, and normalizing unregulated injectables through relatable posts is a meaningful public health concern.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What's this video probably claiming?

At first glance, this looks like a wholesome "first-time auntie" moment. But the video sits firmly in FormBlends' peptide category, which means the creator, Carly Scarlato, is likely weaving peptide content into a relatable lifestyle post. The play here is familiar: soften a clinical topic with personal warmth, then introduce a product or practice. Based on the category tag and creator context, this video probably touches on peptides in the context of recovery, wellness, or longevity, possibly framed around the idea of "taking care of yourself so you can show up for the people you love." It's an emotionally effective hook. It's also a format that tends to fast-track past the skepticism most people would apply to a straightforward product pitch. We don't have the transcript yet, so this is a structural read. But the pattern is consistent enough to flag before the words are even confirmed.

What does the science actually show?

Peptides are short amino acid chains that interact with various biological pathways. Some have legitimate research behind them in specific contexts. BPC-157, for instance, has shown accelerated tendon and gut healing in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but zero published randomized controlled trials in humans as of 2024. GHK-Cu has demonstrated collagen-stimulating properties in vitro (Pickart et al., 2015, Journal of Aging Research), but in vitro is not your skin or your liver. CJC-1295 combined with ipamorelin raises growth hormone levels, with one study showing a 2-10 fold pulse increase (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), but that study used a controlled clinical population, not the general wellness crowd buying compounded vials online. The gap between "works in a lab setting" and "works safely in an unsupervised adult spoiling their nephew" is substantial and largely unmapped.

Where does the social media noise diverge from clinical reality?

The lifestyle-adjacent peptide post is a specific kind of misinformation risk. It doesn't make dramatic health claims. It just normalizes peptide use as part of a healthy, loving, put-together life. That normalization is arguably more effective at driving behavior than a direct claim. Here's what gets left out: most therapeutic peptides sold through compounding pharmacies in the U.S. are not FDA-approved for the conditions being implied. The FDA removed BPC-157 and TB-500 from the bulk substances list in 2023, meaning compounded versions are now in a legal gray zone. Semax and selank are not approved in the U.S. at all. MK-677 is not a peptide, it's a growth hormone secretagogue, and it's not approved for human use in the U.S. outside of clinical trials. None of this tends to make the TikTok caption. The hashtags do not include any of that context.

What should you actually know?

If you're encountering peptide content dressed up in feel-good lifestyle framing, here's the actual checklist worth running:

  • No peptide in this category has FDA approval for general wellness use. That's not a technicality, that's a meaningful data gap.
  • Compounded peptides vary in purity and concentration. A 2021 analysis published in JAMA found significant potency deviations in compounded hormone preparations, and peptides carry similar manufacturing risks.
  • Growth hormone axis peptides like CJC-1295 and ipamorelin carry real risks including insulin resistance, fluid retention, and joint pain, even at doses used in studies.
  • "Taking care of yourself" is a legitimate goal. Injecting unregulated compounds because a TikTok creator made it look warm and relatable is not a sound path to that goal.
  • If peptide therapy genuinely interests you, that conversation belongs in a clinical setting with bloodwork, a licensed provider, and informed consent, not a comment section.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Carly Scarlato · TikTok creator

29.6K views on this video

Can’t wait to spoil you 🫶🏼 #auntie #aunt #firsttimeauntie #firsttimeaunt #babyboy #baby

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no peptide in this category holds fda approval for general?

No peptide in this category holds FDA approval for general wellness or anti-aging use as of 2024.

What does the video say about bpc-157?

BPC-157 and TB-500 were removed from the FDA's compounding bulk substances list in 2023, creating legal and safety uncertainty for compounded versions.

What does the video say about human rct evidence for most wellness peptide claims?

Human RCT evidence for most wellness peptide claims is either absent or based on small, tightly controlled clinical populations that don't represent general use.

What does the video say about growth hormone-stimulating peptides carry documented adverse effects including insulin resistance,?

Growth hormone-stimulating peptides carry documented adverse effects including insulin resistance, fluid retention, and joint pain even in supervised study settings.

What does the video say about compounded peptide preparations can vary significantly in potency?

Compounded peptide preparations can vary significantly in potency and purity, a risk that lifestyle content rarely addresses.

What does the video say about mk-677, often grouped with peptides,?

MK-677, often grouped with peptides, is a synthetic secretagogue not approved for human use outside of clinical trials in the U.S.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Carly Scarlato, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.